This paper aims to analysis the Price Disclosure system of genetic drugs in Australia. After studying the background and historical evolution,the paper track each step of Price Disclosure on the basis of descriptive statistics and analysis in order to provide reference for our country under the health care reform and achieve remarkable success.
参考文献
相似文献
引证文献
引用本文
丁锦希,黄泽华,钭江苑.价格披露制度在澳大利亚仿制药定价中的应用与评价[J].中国卫生经济,2017,(3):93-96.价格披露制度在澳大利亚仿制药定价中的应用与评价[J]. CHINESE HEALTH ECONOMICS,2017,(3):93-96.